AlphaStocks
5.4
Consider Buy

ABBOTT LABORATORIES (ABT)

Health Care / Health Care Equipment

S&P 500

$105.73

Below average on several measures. Research carefully.

Consider Buy

Score based on 5 of 5 models — high confidence

#403out of 1123 in Health Care

Is ABBOTT LABORATORIES a Good Investment in 2026?

ABBOTT LABORATORIES (ABT) scores 5.4 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Buffett model rates ABBOTT LABORATORIES as Strong. The Lynch model is the least favorable, rating it Neutral. ABBOTT LABORATORIES currently trades below its estimated fair value of $107, suggesting potential upside. ABBOTT LABORATORIES ranks #403 out of 1123 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E28.3ROE12.7Market Cap185BDiv Yield2.5

Estimated Fair Value

$107.101% below

Trading near estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Strong

Business quality & competitive moat

Graham

Neutral

88% above fair value

Lynch

Neutral

PEG 3.4 · Stalwart

Greenblatt

Attractive

Top 25% (rank 18%)

Frequently Asked Questions

Is ABBOTT LABORATORIES (ABT) a good investment?
Based on AlphaStocks' composite analysis, ABBOTT LABORATORIES (ABT) scores 5.4 out of 10, earning a Consider Buy rating. This score is below average, suggesting caution. Trading near estimated fair value.
What is ABBOTT LABORATORIES's Piotroski F-Score?
ABBOTT LABORATORIES's Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is ABT overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $107, ABT appears undervalued. The stock currently trades 1% below its estimated fair value. Trading near estimated fair value.
How does ABT compare to other Health Care stocks?
ABBOTT LABORATORIES ranks #403 out of 1123 stocks in the Health Care sector, placing it in the top 36% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about ABT?
AlphaStocks evaluates ABT using five proven investment models. Piotroski: Attractive; Buffett: Strong; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 5.4/10.

Similar Stocks

PARRBFAMNTAP

Compare ABT with

ABT vs PARRABT vs BFAMABT vs NTAP

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer